Kidney transplantation

Kidney transplantation has been studied in 156 papers since 2016: 108 observational studies in people, 3 in animals, 42 reviews; 38 in the past year. Its furthest trials in people are at phase 2. The newest story, Oct 30, 2026: “Incompatible living-donor kidney transplants tied to longer survival”.

ExposurePhase 2

156 papers study it101 findingsUpdated

MeSH

5 new papers in 30 daysSee all 155 papers on kidney transplantation

At a glance

Independent labs found the same change in people. 45 independent labs in 22 countries; 7 trials, none about aging, 1 with no results posted.

“This age acceleration was significantly reduced 1 year after KT, but not after 1 year of dialysis.”
Epigenetic clocks indicate that kidney transplantation and not dialysis mitigate the effects of renal ageingJournal of internal medicine2023doi:10.1111/joim.13724

6 of its findings point the other way.

Humans: replicated by independent labs. Mice: a single group. Cells and worms or flies: nothing yet.
  • 45 independent labs in 22 countries
  • 6 findings against
  • 7 trials, none about aging, 1 with no results posted
  • Funders: National Institute of Diabetes and Digestive and Kidney Diseases and others
  • Humans107
  • Animals3
  • In silico1

What did studies of kidney transplantation find?

45

Studies of kidney transplantation measured 45 outcomes; the most studied are frailty (7 studies), survival (6) and lifespan (3).

Frailty

downin humans7−67% patients

7 studies
  1. Kidney transplantation is linked with lower frailty in adults with kidney failure.

    Humansin adults with kidney failure

  2. Kidney transplantation is linked with lower frailty in humans (67% of patients).

    Humans12 months

  3. Kidney transplantation is linked with lower frailty in humans (mean 4 to 3, p < 0.01).

    Humans6 monthsn = 57

  4. Kidney transplantation is linked with lower frailty in humans (69.9% reduction (15.6% vs 4.7%, p = 0.023)).

    Humans12 monthsn = 64

  5. Kidney transplantation is linked with lower frailty in humans (aOR 0.96, 95% CI: 0.95, 0.98).

    Humansfirst 2.5 years post-KTn = 1,336

  6. Kidney transplantation decreases frailty in humans after kidney transplantation.

    Reviewafter kidney transplantation

  7. Kidney transplantation decreases frailty in patients with ESRD.

    Reviewin patients with ESRD

Survival

upin humans5downin humans1

6 studies
  1. Kidney transplantation is linked with worse survival in humans with CVD (p = 0.004).

    Humanswith CVD

  2. Kidney transplantation is linked with better survival in humans (end-stage renal disease candidates for first deceased donor kidney transplantation).

    Humansend-stage renal disease candidates for first deceased donor kidney transplantation

  3. Kidney transplantation is linked with better survival in humans (92.7% and 66.9% vs 73.3% and 42.8% (OTO) and 70.9% and 40.6% (YTO)).

    Humansn = 593

  4. Kidney transplantation increases survival in humans (some frail patients with end-stage kidney disease).

    Reviewsome frail patients with end-stage kidney disease

  5. Kidney transplantation increases survival in humans (people with HIV and end-stage kidney disease).

    Reviewpeople with HIV and end-stage kidney disease

  6. Kidney transplantation improves survival in eligible patients.

    Reviewin eligible patients

Lifespan

upin humans3

3 studies
  1. Kidney transplantation is linked with longer lifespan in humans (older patients on deceased donor waitlist) (overall LYFT=5 years).

    Humansolder patients on deceased donor waitlist

  2. Kidney transplantation improves lifespan in humans (kidney failure).

    Reviewkidney failure

  3. Kidney transplantation extends lifespan in humans (compared with remaining on dialysis).

    Reviewcompared with remaining on dialysis

Graft survival

no changein humans2

2 studies
  1. Kidney transplantation was not clearly linked with graft survival in humans (kidneys from donors aged 70 or older compared with younger donors) (3-year graft survival 80% vs 88.6% in control group).

    Humanskidneys from donors aged 70 or older compared with younger donorskidneys from donors aged 70 years or olderkidneyn = 27

  2. Kidney transplantation showed no clear effect on graft survival in humans (comparing recipients aged ≥ 70 years to < 70 years).

    Reviewcomparing recipients aged ≥ 70 years to < 70 yearskidneyn = 272,982

Cellular senescence

upin humans1no changein humans1

2 studies
  1. Kidney transplantation is linked with higher cellular senescence in humans.

    Humansblood3 monthsn = 91

  2. Kidney transplantation was not clearly linked with cellular senescence in humans (living-donor ABO-compatible kidney transplantation).

    Humansliving-donor ABO-compatible kidney transplantationkidneyone yearn = 9

More on Cellular senescence

Quality of life

upin humans2

2 studies
  1. Kidney transplantation improves quality of life in humans.

    Review

  2. Kidney transplantation improves quality of life in humans.

    Review

Fracture

no changein humans1

1 study
  1. Kidney transplantation was not clearly linked with fracture in humans (kidney transplant recipients vs waitlisted dialysis patients) (9.1% vs 12.5%).

    Humanskidney transplant recipients vs waitlisted dialysis patients

5-year survival

downin humans1RR 0.86

1 study
  1. Kidney transplantation decreases 5-year survival in recipients aged ≥ 70 years compared to < 70 years (RR = 0.86 (95% CI 0.81-0.92; p = 0.02)).

    Reviewin recipients aged ≥ 70 years compared to < 70 years5 yearsn = 272,982

Patient survival

downin humans1RR 0.87

1 study
  1. Kidney transplantation decreases patient survival in recipients aged ≥ 70 years compared to < 70 years (RR = 0.87 (95% CI 0.77-0.99; p = 0.04)).

    Reviewin recipients aged ≥ 70 years compared to < 70 yearsn = 272,982

Overall survival

no changein humans1HR 0.94

1 study
  1. Kidney transplantation was not clearly linked with overall survival in humans (elderly ESRD patients, time-dependent Cox model) (HR = 0.94, p = 0.837).

    Humanselderly ESRD patients, time-dependent Cox modeln = 1,060

Epigenetic age

downin humans1

1 study
  1. Kidney transplantation decreases epigenetic age in CKD G5.

    Human trialin CKD G5blood1 yearn = 47

More on Epigenetic age

Age-associated B cells

upin humans1

1 study
  1. Kidney transplantation increases age-associated B cells in humans after kidney transplantation.

    Human trialafter kidney transplantationmedian 2.7 years

More on Age-associated B cells

CD28- T cells

upin humans1

1 study
  1. Kidney transplantation increases CD28- T cells in humans after kidney transplantation.

    Human trialafter kidney transplantationmedian 2.7 years

More on CD28- T cells

All 45

What is kidney transplantation linked with?

28

Studies link kidney transplantation with 28 measures, most often mortality (8 studies).

Mortality

downin humans6upin humans2no changein humans1HR 0.17–1.15

8 studies
  1. Kidney transplantation is associated with mortality in humans (Compared with dialysis patients) (SMR 0.39, 95% CI 0.37–0.40; estimated survival advantage 8–11 years).

    HumansCompared with dialysis patientsmedian 11.1 years

  2. Kidney transplantation is associated with mortality in humans (ESKD; compared with remaining on the waitlist) (HR 0.30, 95% CI 0.15–0.62).

    HumansESKD; compared with remaining on the waitlist

    Incompatible living-donor kidney transplants tied to longer survival

    International journal of surgery (London, England)
  3. Kidney transplantation is associated with mortality in humans (compared with non-dialysis-dependent CKD patients) (adjusted HR 0.57, 95% CI 0.33-1.01).

    Humanscompared with non-dialysis-dependent CKD patientsmedian follow-up period of 88 months

  4. Kidney transplantation is linked with a lower risk of mortality in humans (HR: 0.68, 95% CI: 0.59-0.80, P < 0.001).

    Humans

  5. Kidney transplantation is linked with a lower risk of mortality in humans (kidney failure awaiting transplantation) (HR 0.17, 95% c.i. 0.16 to 0.18).

    Humanskidney failure awaiting transplantationn = 47,917

  6. Kidney transplantation is linked with a lower risk of mortality in humans (2015 to March 14, 2020 compared to 1990-1994) (aHR 0.61, 95% CI 0.50-0.75).

    Humans2015 to March 14, 2020 compared to 1990-1994

  7. Kidney transplantation is linked with a higher risk of mortality in humans (old-to-old KT recipients vs young recipients) (aHR 2.89, 95% CI 1.14-7.32).

    Humansold-to-old KT recipients vs young recipients

  8. Kidney transplantation is linked with a higher risk of mortality in humans (HR 1.15 (95% CI 1.03-1.27)).

    HumansKDPI >85% non-preemptive transplant in recipients older than 60 years, first year posttransplant, compared with waitlisthigh KDPI, non-preemptivefirst year posttransplant

  9. Kidney transplantation is linked with a lower risk of mortality in humans (HR 0.61 (95% CI 0.41-0.90)).

    HumansKDPI >85% preemptive transplant in recipients older than 60 years, first year posttransplant, compared with waitlisthigh KDPI, preemptivefirst year posttransplant

Cancer-specific mortality

upin humans1

1 study
  1. Kidney transplantation is associated with cancer-specific mortality in humans (Compared with dialysis patients) (SMR 1.12, 95% CI 1.04–1.20).

    HumansCompared with dialysis patientsmedian 11.1 years

Cancer incidence

upin humans1

1 study
  1. Kidney transplantation is associated with cancer incidence in humans (Compared with dialysis patients) (SIR 1.10, 95% CI 1.05–1.15).

    HumansCompared with dialysis patientsmedian 9.6 years

Mild cognitive impairment

downin humans1

1 study
  1. Kidney transplantation is associated with mild cognitive impairment in humans (kidney transplant recipients) (prevalence 42.6% to 31.3%).

    Humanskidney transplant recipientsup to 2 yearsn = 230

    Frailty and cognitive impairment decline after kidney transplant

    Transplant international : official journal of the European Society for Organ Transplantation

More on Mild cognitive impairment

Pre-frailty

downin humans1

1 study
  1. Kidney transplantation is associated with pre-frailty in humans (kidney transplant recipients) (54.3% to 27.6% at 2 years).

    Humanskidney transplant recipients2 yearsn = 230

    Frailty and cognitive impairment decline after kidney transplant

    Transplant international : official journal of the European Society for Organ Transplantation

Physical frailty

downin humans1

1 study
  1. Kidney transplantation is associated with physical frailty in humans (kidney transplant recipients) (8.3% before transplantation to below 2% during follow-up).

    Humanskidney transplant recipientsup to 2 yearsn = 230

    Frailty and cognitive impairment decline after kidney transplant

    Transplant international : official journal of the European Society for Organ Transplantation

Cancer

no changein humans1HR 1.35

1 study
  1. Kidney transplantation is associated with cancer in humans (compared with non-dialysis-dependent CKD patients) (HR 1.35, 0.75-2.46).

    Humanscompared with non-dialysis-dependent CKD patientsmedian follow-up period of 88 months

More on Cancer

Infection-related hospitalizations

upin humans1HR 3.91

1 study
  1. Kidney transplantation is linked with a higher risk of infection-related hospitalizations in humans (compared with non-dialysis-dependent CKD patients) (HR 3.91, 95% CI 2.66-5.74).

    Humanscompared with non-dialysis-dependent CKD patientsmedian follow-up period of 88 months

End-stage renal disease

upin humans1HR 3.51

1 study
  1. Kidney transplantation is linked with a higher risk of end-stage renal disease in humans (compared with non-dialysis-dependent CKD patients) (HR 3.51, 95% CI 1.07-11.5).

    Humanscompared with non-dialysis-dependent CKD patientsmedian follow-up period of 88 months

More on End-stage renal disease

Cardiovascular events

no changein humans1HR 1.31

1 study
  1. Kidney transplantation is associated with cardiovascular events in humans (compared with non-dialysis-dependent CKD patients) (HR 1.31, 95% CI 0.42-4.05).

    Humanscompared with non-dialysis-dependent CKD patientsmedian follow-up period of 88 months

More on Cardiovascular events

All 28

What acts on kidney transplantation?

3

Studies name 3 things that act on kidney transplantation: frailty, geriatric assessment and FRAIL Scale.

Frailty

downin humans2HR 0.45

2 studies
  1. Frailty is linked with lower kidney transplantation in humans (advanced chronic kidney disease or maintenance hemodialysis).

    Humansadvanced chronic kidney disease or maintenance hemodialysisn = 256

  2. Frailty is linked with lower kidney transplantation in humans (multivariable analysis) (HR 0.45 [0.26-0.77]).

    Humansmultivariable analysisn = 449

Geriatric assessment

upin humans1

1 study
  1. Geriatric assessment is linked with higher kidney transplantation in humans.

    Humansn = 171

More on Geriatric assessment

FRAIL Scale

no changein humans1

1 study
  1. FRAIL Scale was not clearly linked with kidney transplantation in humans.

    Humansn = 449

More on FRAIL Scale

Has kidney transplantation been tested in people?

0 of 7 about aging

Yes: 108 observational studies in people have been published, and 7 trials are registered.

In trials

Trial sponsors

Funding

10 grants since 2018

National Institute of Diabetes and Digestive and Kidney Diseases$2.3MNational Institute on Aging$769KJapan Society for the Promotion of Science¥8.8M

Latest

Dec 2025: 3Jan 2026: 5Feb 2026: 0Mar 2026: 4Apr 2026: 2May 2026: 2Jun 2026: 5Jul 2026: 3Aug 2026: 2Sep 2026: 5Oct 2026: 5Nov 2026: 036 papers in 12 months
International Journal of Surgery

Incompatible living-donor kidney transplants tied to longer survival

Ten-year survival was 86.3% after incompatible living-donor transplants versus 56.8% with standard waitlist care in matched patients aged 60 or older.Ten-year survival was 86.3% after incompatible living-donor transplants versus 56.8% with standard waitlist care in matched patients aged 60 or older.

Cohort · 1,819 peopleKidney
Clinical Transplantation

Bone screening lagged behind risk after kidney transplants

Among 34,758 adults, 29.9% received bone density testing within a year of transplantation, compared with 63.8% over a median 8.4-year follow-up.Among 34,758 adults, 29.9% received bone density testing within a year of transplantation, compared with 63.8% over a median 8.4-year follow-up.

Cohort · 34,758 peopleBones and joints
bioRxiv

Pig kidneys recovered function after ultra-cold storage

Kidneys 100-fold larger than those previously rewarmed with this method recovered function after up to one year at minus 150 degrees Celsius.Kidneys 100-fold larger than those previously rewarmed with this method recovered function after up to one year at minus 150 degrees Celsius.

Preprint: animal studyKidney
BMJ

Kidney transplant survival advantage varied by donor and age

Among 75-year-olds, estimated five-year survival was 59% after expanded-criteria donor transplants following circulatory death versus 55% with continued dialysis, without…Among 75-year-olds, estimated five-year survival was 59% after expanded-criteria donor transplants following circulatory death versus 55% with continued dialysis, without a statistically clear difference.

Cohort · 64,036 peopleKidney

See all 155 papers on kidney transplantation